Skip to main content
Clinical Trials/JPRN-UMIN000005360
JPRN-UMIN000005360
Completed
N/A

Effect of subthalamic nucleus stimulation for pain related to Parkinson's disease - STN stimulation for PD-related pain

ihon University School of Medicine0 sites70 target enrollmentApril 1, 2011

Overview

Phase
N/A
Intervention
Not specified
Conditions
Parkinson disease
Sponsor
ihon University School of Medicine
Enrollment
70
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Several types of pain related to PD, the categories of which were based on a modification of two previous classifications (Ford and Honey), can occur in such patients: 1) musculoskeletal pain, 2) dystonic pain, 3) somatic pain exacerbated by PD, 4) radiculo-peripheral neuropathic pain, and 5) central pain. The overall mean VAS score was significantly decreased by 75% and 69% at 2 weeks and 6 months postoperatively (p 0.001). The mean VAS score at 12 months was also decreased by 80%; however, 6 instances of pain (3 of somatic back pain and 3 of radiculo-peripheral neuropathic pain) required additional spinal surgery to alleviate their severity. The results were analyzed using Wilcoxon's signed-ranks test, and demonstrated a significant reduction in VAS scores at all follow-up assessment times (p<0.001). Musculoskeletal pain and dystonic pain were well alleviated by STN stimulation. In contrast, somatic pain exacerbated by PD and peripheral neuropathic pain originating from lumbar spinal diseases, such as spondylosis deformans and/or canal stenosis, often deteriorated postoperatively despite their motor disability being attenuated. Patients with central pain were poor responders.

Registry
who.int
Start Date
April 1, 2011
End Date
January 1, 2009
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
ihon University School of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients with major depression or cognitive dysfunction (Mini\-Mental Status Examination score \< 23\) are excluded as candidates for surgery.

Outcomes

Primary Outcomes

Not specified

Similar Trials